{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:08:22Z","timestamp":1792872502593,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T00:00:00Z","timestamp":1669420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ferroptosis induced by detrimental accumulation of lipid peroxides has been recently linked to a variety of pathological conditions ranging from acute tissue injuries to chronic degenerative diseases and suppression of ferroptosis by small chemical inhibitors is beneficial to the prevention and treatment of these diseases. However, in vivo applicable small chemical ferroptosis inhibitors are limited currently. In this study, we screened an alkaloid natural compound library for compounds that can inhibit RSL3-induced ferroptosis in HT1080 cells and identified a group of bisbenzylisoquinoline (BBIQ) compounds as novel ferroptosis-specific inhibitors. These BBIQ compounds are structurally different from known ferroptosis inhibitors and they do not appear to regulate iron homeostasis or lipid ROS generation pathways, while they are able to scavenge 1,1-diphenyl-2-picryl-hydrazyl (DPPH) in cell-free reactions and prevent accumulation of lipid peroxides in living cells. These BBIQ compounds demonstrate good in vivo activities as they effectively protect mice from folic acid-induced renal tubular ferroptosis and acute kidney injury. Several BBIQ compounds are approved drugs in Japan and China for traditional uses and cepharanthine is currently in clinical trials against SARS-CoV-2, our discovery of BBIQs as in vivo applicable ferroptosis inhibitors will expand their usage to prevent ferroptotic tissue damages under various pathological conditions.<\/jats:p>","DOI":"10.1038\/s41419-022-05447-8","type":"journal-article","created":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T01:25:02Z","timestamp":1669512302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Identification of a group of bisbenzylisoquinoline (BBIQ) compounds as ferroptosis inhibitors"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2317-1158","authenticated-orcid":false,"given":"Yipu","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5222-014X","authenticated-orcid":false,"given":"Duanqing","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9145-7887","authenticated-orcid":false,"given":"Xiaodong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,26]]},"reference":[{"key":"5447_CR1","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"5447_CR2","doi-asserted-by":"publisher","first-page":"E4966","DOI":"10.1073\/pnas.1603244113","volume":"113","author":"WS Yang","year":"2016","unstructured":"Yang WS, Kim KJ, Gaschler MM, Patel M, Shchepinov MS, Stockwell BR. Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis. Proc Natl Acad Sci USA. 2016;113:E4966\u201375.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5447_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","volume":"585","author":"Y Zou","year":"2020","unstructured":"Zou Y, Henry WS, Ricq EL, Graham ET, Phadnis VV, Maretich P, et al. Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Nature 2020;585:603\u20138.","journal-title":"Nature"},{"key":"5447_CR4","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 2014;156:317\u201331.","journal-title":"Cell"},{"key":"5447_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K Bersuker","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, Magtanong L, Ford B, Tang PH, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 2019;575:688\u201392.","journal-title":"Nature"},{"key":"5447_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","volume":"575","author":"S Doll","year":"2019","unstructured":"Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I, et al. FSP1 is a glutathione-independent ferroptosis suppressor. Nature 2019;575:693\u20138.","journal-title":"Nature"},{"key":"5447_CR7","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","volume":"16","author":"M Soula","year":"2020","unstructured":"Soula M, Weber RA, Zilka O, Alwaseem H, La K, Yen F, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers. Nat Chem Biol. 2020;16:1351\u201360.","journal-title":"Nat Chem Biol"},{"key":"5447_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","volume":"6","author":"VAN Kraft","year":"2020","unstructured":"Kraft VAN, Bezjian CT, Pfeiffer S, Ringelstetter L, Muller C, Zandkarimi F, et al. GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling. ACS Cent Sci. 2020;6:41\u201353.","journal-title":"ACS Cent Sci"},{"key":"5447_CR9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","volume":"593","author":"C Mao","year":"2021","unstructured":"Mao C, Liu X, Zhang Y, Lei G, Yan Y, Lee H, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer. Nature 2021;593:586\u201390.","journal-title":"Nature"},{"key":"5447_CR10","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16:1180\u201391.","journal-title":"Nat Cell Biol"},{"key":"5447_CR11","doi-asserted-by":"publisher","first-page":"16836","DOI":"10.1073\/pnas.1415518111","volume":"111","author":"A Linkermann","year":"2014","unstructured":"Linkermann A, Skouta R, Himmerkus N, Mulay SR, Dewitz C, De Zen F, et al. Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci USA. 2014;111:16836\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5447_CR12","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1681\/ASN.2015121376","volume":"28","author":"D Martin-Sanchez","year":"2017","unstructured":"Martin-Sanchez D, Ruiz-Andres O, Poveda J, Carrasco S, Cannata-Ortiz P, Sanchez-Nino MD, et al. Ferroptosis, but not necroptosis, is important in nephrotoxic folic acid-induced AKI. J Am Soc Nephrology. 2017;28:218\u201329.","journal-title":"J Am Soc Nephrology"},{"key":"5447_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41419-020-2256-z","volume":"11","author":"Z Hu","year":"2020","unstructured":"Hu Z, Zhang H, Yi B, Yang S, Liu J, Hu J, et al. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis. Cell Death Dis. 2020;11:73.","journal-title":"Cell Death Dis"},{"key":"5447_CR14","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D, Xie E, Yang X, Wei J, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci USA. 2019;116:2672\u201380.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5447_CR15","doi-asserted-by":"publisher","first-page":"28097","DOI":"10.1074\/jbc.M115.680090","volume":"290","author":"L Chen","year":"2015","unstructured":"Chen L, Hambright WS, Na R, Ran Q. Ablation of the ferroptosis inhibitor glutathione peroxidase 4 in neurons results in rapid motor neuron degeneration and paralysis. J Biol Chem. 2015;290:28097\u2013106.","journal-title":"J Biol Chem"},{"key":"5447_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","volume":"9","author":"BA Carlson","year":"2016","unstructured":"Carlson BA, Tobe R, Yefremova E, Tsuji PA, Hoffmann VJ, Schweizer U, et al. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 2016;9:22\u201331.","journal-title":"Redox Biol"},{"key":"5447_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15646-6","volume":"11","author":"L Mayr","year":"2020","unstructured":"Mayr L, Grabherr F, Schwarzler J, Reitmeier I, Sommer F, Gehmacher T, et al. Dietary lipids fuel GPX4-restricted enteritis resembling Crohn\u2019s disease. Nat Commun. 2020;11:1775.","journal-title":"Nat Commun"},{"key":"5447_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.imlet.2020.06.005","volume":"225","author":"Y Chen","year":"2020","unstructured":"Chen Y, Zhang P, Chen W, Chen G. Ferroptosis mediated DSS-induced ulcerative colitis associated with Nrf2\/HO-1 signaling pathway. Immunol Lett. 2020;225:9\u201315.","journal-title":"Immunol Lett"},{"key":"5447_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1734-1140(11)70500-X","volume":"63","author":"M Rogosnitzky","year":"2011","unstructured":"Rogosnitzky M, Danks R. Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions. Pharmacol Rep. 2011;63:337\u201347.","journal-title":"Pharmacol Rep"},{"key":"5447_CR20","doi-asserted-by":"publisher","first-page":"152956","DOI":"10.1016\/j.phymed.2019.152956","volume":"62","author":"C Bailly","year":"2019","unstructured":"Bailly C. Cepharanthine: an update of its mode of action, pharmacological properties and medical applications. Phytomedicine: Int J Phytother Phytopharmacol. 2019;62:152956.","journal-title":"Phytomedicine: Int J Phytother Phytopharmacol"},{"key":"5447_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/molecules23102538","volume":"23","author":"M Merarchi","year":"2018","unstructured":"Merarchi M, Sethi G, Fan L, Mishra S, Arfuso F, Ahn KS. Molecular targets modulated by fangchinoline in tumor cells and preclinical models. Molecules 2018;23:10.","journal-title":"Molecules"},{"key":"5447_CR22","doi-asserted-by":"publisher","first-page":"630385","DOI":"10.3389\/fphar.2021.630385","volume":"12","author":"Y Cheng","year":"2021","unstructured":"Cheng Y, Li HL, Zhou ZW, Long HZ, Luo HY, Wen DD, et al. Isoliensinine: a natural compound with \u201cdrug-like\u201d potential. Front Pharmacol. 2021;12:630385.","journal-title":"Front Pharmacol"},{"key":"5447_CR23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.lfs.2018.02.032","volume":"199","author":"S Marthandam Asokan","year":"2018","unstructured":"Marthandam Asokan S, Mariappan R, Muthusamy S, Velmurugan BK. Pharmacological benefits of neferine\u2014a comprehensive review. Life Sci. 2018;199:60\u201370.","journal-title":"Life Sci"},{"key":"5447_CR24","doi-asserted-by":"publisher","first-page":"4295208","DOI":"10.1155\/2022\/4295208","volume":"2022","author":"S Gao","year":"2022","unstructured":"Gao S, Zhou L, Lu J, Fang Y, Wu H, Xu W, et al. Cepharanthine attenuates early brain injury after subarachnoid hemorrhage in mice via inhibiting 15-lipoxygenase-1-mediated microglia and endothelial cell ferroptosis. Oxid Med Cell Longev. 2022;2022:4295208.","journal-title":"Oxid Med Cell Longev"},{"key":"5447_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1084\/jem.20140857","volume":"212","author":"M Matsushita","year":"2015","unstructured":"Matsushita M, Freigang S, Schneider C, Conrad M, Bornkamm GW, Kopf M. T cell lipid peroxidation induces ferroptosis and prevents immunity to infection. J Exp Med. 2015;212:555\u201368.","journal-title":"J Exp Med"},{"key":"5447_CR26","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","volume":"32","author":"J Zheng","year":"2020","unstructured":"Zheng J, Conrad M. The metabolic underpinnings of ferroptosis. Cell Metab. 2020;32:920\u201337.","journal-title":"Cell Metab"},{"key":"5447_CR27","doi-asserted-by":"publisher","first-page":"174461","DOI":"10.1016\/j.ejphar.2021.174461","volume":"914","author":"C Peng","year":"2022","unstructured":"Peng C, Fu X, Wang K, Chen L, Luo B, Huang N, et al. Dauricine alleviated secondary brain injury after intracerebral hemorrhage by upregulating GPX4 expression and inhibiting ferroptosis of nerve cells. Eur J Pharmacol. 2022;914:174461.","journal-title":"Eur J Pharmacol"},{"key":"5447_CR28","first-page":"7933775","volume":"2022","author":"S Li","year":"2022","unstructured":"Li S, Zhang Y, Zhang J, Yu B, Wang W, Jia B, et al. Neferine exerts ferroptosis-inducing effect and antitumor effect on thyroid cancer through Nrf2\/HO-1\/NQO1 inhibition. J Oncol. 2022;2022:7933775.","journal-title":"J Oncol"},{"key":"5447_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0304-4165(98)00146-9","volume":"1426","author":"K Kogure","year":"1999","unstructured":"Kogure K, Goto S, Abe K, Ohiwa C, Akasu M, Terada H. Potent antiperoxidation activity of the bisbenzylisoquinoline alkaloid cepharanthine: the amine moiety is responsible for its pH-dependent radical scavenge activity. Biochim Biophys Acta. 1999;1426:133\u201342.","journal-title":"Biochim Biophys Acta"},{"key":"5447_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-4165(03)00095-3","volume":"1622","author":"K Kogure","year":"2003","unstructured":"Kogure K, Tsuchiya K, Abe K, Akasu M, Tamaki T, Fukuzawa K, et al. Direct radical scavenging by the bisbenzylisoquinoline alkaloid cepharanthine. Biochim Biophys Acta. 2003;1622:1\u20135.","journal-title":"Biochim Biophys Acta"},{"key":"5447_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1358\/mf.1998.20.2.485636","volume":"20","author":"S Furusawa","year":"1998","unstructured":"Furusawa S, Wu J, Fujimura T, Nakano S, Nemoto S, Takayanagi M, et al. Cepharanthine inhibits proliferation of cancer cells by inducing apoptosis. Methods Find Exp Clin Pharmacol. 1998;20:87\u201397.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"5447_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.febslet.2005.12.048","volume":"580","author":"KK Biswas","year":"2006","unstructured":"Biswas KK, Tancharoen S, Sarker KP, Kawahara K, Hashiguchi T, Maruyama I. Cepharanthine triggers apoptosis in a human hepatocellular carcinoma cell line (HuH-7) through the activation of JNK1\/2 and the downregulation of Akt. FEBS Lett. 2006;580:703\u201310.","journal-title":"FEBS Lett"},{"key":"5447_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.bbrc.2015.02.131","volume":"460","author":"P Hua","year":"2015","unstructured":"Hua P, Sun M, Zhang G, Zhang Y, Tian X, Li X, et al. Cepharanthine induces apoptosis through reactive oxygen species and mitochondrial dysfunction in human non-small-cell lung cancer cells. Biochem Biophys Res Commun. 2015;460:136\u201342.","journal-title":"Biochem Biophys Res Commun"},{"key":"5447_CR34","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/j.jsps.2020.08.026","volume":"28","author":"K Cierluk","year":"2020","unstructured":"Cierluk K, Szlasa W, Rossowska J, Tarek M, Szewczyk A, Saczko J, et al. Cepharanthine induces ROS stress in glioma and neuronal cells via modulation of VDAC permeability. Saudi Pharm J. 2020;28:1364\u201373.","journal-title":"Saudi Pharm J."},{"key":"5447_CR35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41589-021-00751-4","volume":"17","author":"M Conlon","year":"2021","unstructured":"Conlon M, Poltorack CD, Forcina GC, Armenta DA, Mallais M, Perez MA, et al. A compendium of kinetic modulatory profiles identifies ferroptosis regulators. Nat Chem Biol. 2021;17:665\u201374.","journal-title":"Nat Chem Biol"},{"key":"5447_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jss.2010.01.025","volume":"171","author":"J Kusaka","year":"2011","unstructured":"Kusaka J, Hagiwara S, Hasegawa A, Kudo K, Koga H, Noguchi T. Cepharanthine improves renal ischemia-reperfusion injury in rats. J Surgical Res. 2011;171:212\u20137.","journal-title":"J Surgical Res"},{"key":"5447_CR37","doi-asserted-by":"publisher","first-page":"504061","DOI":"10.1155\/2015\/504061","volume":"2015","author":"MC Kao","year":"2015","unstructured":"Kao MC, Chung CY, Chang YY, Lin CK, Sheu JR, Huang CJ. Salutary effects of cepharanthine against skeletal muscle and kidney injuries following limb ischemia\/reperfusion. Evid Based Complement Alternat Med. 2015;2015:504061.","journal-title":"Evid Based Complement Alternat Med"},{"key":"5447_CR38","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.lfs.2013.01.031","volume":"92","author":"N Sogawa","year":"2013","unstructured":"Sogawa N, Hirai K, Sogawa C, Ohyama K, Miyazaki I, Tsukamoto G, et al. Protective effect of cepharanthin on cisplatin-induced renal toxicity through metallothionein expression. Life Sci. 2013;92:727\u201332.","journal-title":"Life Sci"},{"key":"5447_CR39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.lfs.2016.06.002","volume":"157","author":"YA Samra","year":"2016","unstructured":"Samra YA, Said HS, Elsherbiny NM, Liou GI, El-Shishtawy MM, Eissa LA. Cepharanthine and Piperine ameliorate diabetic nephropathy in rats: role of NF-kappaB and NLRP3 inflammasome. Life Sci. 2016;157:187\u201399.","journal-title":"Life Sci"},{"key":"5447_CR40","doi-asserted-by":"publisher","first-page":"110151","DOI":"10.1016\/j.biopha.2020.110151","volume":"127","author":"J Zhao","year":"2020","unstructured":"Zhao J, Piao X, Wu Y, Liang S, Han F, Liang Q, et al. Cepharanthine attenuates cerebral ischemia\/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12\/15-LOX signaling. Biomed Pharmacother. 2020;127:110151.","journal-title":"Biomed Pharmacother"},{"key":"5447_CR41","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1111\/1751-7915.14059","volume":"15","author":"HG Wang","year":"2022","unstructured":"Wang HG, Zhang MN, Wen X, He L, Zhang MH, Zhang JL, et al. Cepharanthine ameliorates dextran sulphate sodium-induced colitis through modulating gut microbiota. Microb Biotechnol. 2022;15:2208\u201322.","journal-title":"Microb Biotechnol"},{"key":"5447_CR42","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s10571-019-00711-6","volume":"39","author":"F Bao","year":"2019","unstructured":"Bao F, Tao L, Zhang H. Neuroprotective effect of natural alkaloid fangchinoline against oxidative glutamate toxicity: involvement of keap1-Nrf2 axis regulation. Cell Mol Neurobiol. 2019;39:1177\u201386.","journal-title":"Cell Mol Neurobiol"},{"key":"5447_CR43","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/a-0636-3883","volume":"128","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Liu J, Zhou Z, Liu K, Liu C. Fangchinoline protects against renal injury in diabetic nephropathy by modulating the MAPK signaling pathway. Exp Clin Endocrinol Diabetes. 2020;128:499\u2013505.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"5447_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.21037\/atm-20-5669","volume":"8","author":"H Chen","year":"2020","unstructured":"Chen H, Shi Z, Xing Y, Li X, Fu F. Fangchinoline attenuates cardiac dysfunction in rats with endotoxemia via the inhibition of ERK1\/2 and NF-kappaB p65 phosphorylation. Ann Transl Med. 2020;8:1167.","journal-title":"Ann Transl Med"},{"key":"5447_CR45","first-page":"765","volume":"25","author":"ZB Guo","year":"2005","unstructured":"Guo ZB, Fu JG. Progress of cardiovascular pharmacologic study on berbamine. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chin J Integr Traditional West Med. 2005;25:765\u20138.","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chin J Integr Traditional West Med"},{"key":"5447_CR46","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1253\/circj.CJ-11-1431","volume":"76","author":"CM Zhang","year":"2012","unstructured":"Zhang CM, Gao L, Zheng YJ, Yang HT. Berbamine protects the heart from ischemia\/reperfusion injury by maintaining cytosolic Ca(2+) homeostasis and preventing calpain activation. Circulation J. 2012;76:1993\u20132002.","journal-title":"Circulation J"},{"key":"5447_CR47","doi-asserted-by":"publisher","first-page":"e2577","DOI":"10.1038\/cddis.2017.7","volume":"8","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Gu S, Li X, Tan J, Liu S, Jiang Y, et al. Berbamine postconditioning protects the heart from ischemia\/reperfusion injury through modulation of autophagy. Cell Death Dis. 2017;8:e2577.","journal-title":"Cell Death Dis"},{"key":"5447_CR48","first-page":"186","volume":"18","author":"XY Liu","year":"2020","unstructured":"Liu XY, Chen GN, Du GM, Pan Y, Song WQ, Jiang TW, et al. Berbamine ameliorates ethanol-induced liver injury by inhibition of hepatic inflammation in mice. Chin J Nat Med. 2020;18:186\u201395.","journal-title":"Chin J Nat Med"},{"key":"5447_CR49","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3389\/fphar.2019.01197","volume":"10","author":"H Li","year":"2019","unstructured":"Li H, Chen W, Chen Y, Zhou Q, Xiao P, Tang R, et al. Neferine attenuates acute kidney injury by inhibiting NF-kappaB signaling and upregulating klotho expression. Front Pharmacol. 2019;10:1197.","journal-title":"Front Pharmacol"},{"key":"5447_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/bph.14537","volume":"176","author":"C Wu","year":"2019","unstructured":"Wu C, Chen J, Yang R, Duan F, Li S, Chen X. Mitochondrial protective effect of neferine through the modulation of nuclear factor erythroid 2-related factor 2 signalling in ischaemic stroke. Br J Pharmacol. 2019;176:400\u201315.","journal-title":"Br J Pharmacol"},{"key":"5447_CR51","first-page":"523","volume":"22","author":"X Min","year":"2021","unstructured":"Min X, Guo Y, Zhou Y, Chen X. Protection against dextran sulfate sodium-induced ulcerative colitis in mice by neferine, a natural product from nelumbo nucifera gaertn. Cell J. 2021;22:523\u201331.","journal-title":"Cell J"},{"key":"5447_CR52","doi-asserted-by":"publisher","first-page":"104846","DOI":"10.1016\/j.phrs.2020.104846","volume":"157","author":"X Liang","year":"2020","unstructured":"Liang X, Wang S, Wang L, Ceylan AF, Ren J, Zhang Y. Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission. Pharmacol Res. 2020;157:104846.","journal-title":"Pharmacol Res"},{"key":"5447_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-2005-837821","volume":"71","author":"JH Xiao","year":"2005","unstructured":"Xiao JH, Zhang JH, Chen HL, Feng XL, Wang JL. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice. Planta Med. 2005;71:225\u201330.","journal-title":"Planta Med"},{"key":"5447_CR54","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","volume":"30","author":"BR Stockwell","year":"2020","unstructured":"Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 2020;30:478\u201390.","journal-title":"Trends Cell Biol"},{"key":"5447_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"5447_CR56","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","volume":"133","author":"HH Fan","year":"2020","unstructured":"Fan HH, Wang LQ, Liu WL, An XP, Liu ZD, He XQ, et al. Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model. Chin Med J. 2020;133:1051\u20136.","journal-title":"Chin Med J"},{"key":"5447_CR57","doi-asserted-by":"publisher","first-page":"e00819","DOI":"10.1128\/AAC.00819-20","volume":"64","author":"S Jeon","year":"2020","unstructured":"Jeon S, Ko M, Lee J, Choi I, Byun SY, Park S, et al. Identification of antiviral drug candidates against SARS-CoV-2 from FDA-approved drugs. Antimicrob Agents Chemother. 2020;64:e00819\u201320.","journal-title":"Antimicrob Agents Chemother"},{"key":"5447_CR58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41392-020-00343-z","volume":"5","author":"ZR Zhang","year":"2020","unstructured":"Zhang ZR, Zhang YN, Li XD, Zhang HQ, Xiao SQ, Deng F, et al. A cell-based large-scale screening of natural compounds for inhibitors of SARS-CoV-2. Signal Transduct Target Ther. 2020;5:218.","journal-title":"Signal Transduct Target Ther"},{"key":"5447_CR59","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/acsptsci.0c00112","volume":"3","author":"CZ Chen","year":"2020","unstructured":"Chen CZ, Xu M, Pradhan M, Gorshkov K, Petersen JD, Straus MR, et al. Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles. ACS Pharmacol Transl Sci. 2020;3:1165\u201375.","journal-title":"ACS Pharmacol Transl Sci"},{"key":"5447_CR60","doi-asserted-by":"publisher","first-page":"102367","DOI":"10.1016\/j.isci.2021.102367","volume":"24","author":"H Ohashi","year":"2021","unstructured":"Ohashi H, Watashi K, Saso W, Shionoya K, Iwanami S, Hirokawa T, et al. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021;24:102367.","journal-title":"iScience"},{"key":"5447_CR61","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41392-021-00584-6","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang L, Yuen TT, Ye Z, Liu S, Zhang G, Chu H, et al. Berbamine inhibits SARS-CoV-2 infection by compromising TRPMLs-mediated endolysosomal trafficking of ACE2. Signal Transduct Target Ther. 2021;6:168.","journal-title":"Signal Transduct Target Ther"},{"key":"5447_CR62","doi-asserted-by":"publisher","first-page":"e0010363","DOI":"10.1371\/journal.pntd.0010363","volume":"16","author":"ZR Zhang","year":"2022","unstructured":"Zhang ZR, Zhang YN, Zhang HQ, Zhang QY, Li N, Li Q, et al. Berbamine hydrochloride potently inhibits SARS-CoV-2 infection by blocking S protein-mediated membrane fusion. PLoS Neglected Tropical Dis. 2022;16:e0010363.","journal-title":"PLoS Neglected Tropical Dis"},{"key":"5447_CR63","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.1002\/jmv.27117","volume":"93","author":"Y Yang","year":"2021","unstructured":"Yang Y, Yang P, Huang C, Wu Y, Zhou Z, Wang X, et al. Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca(2+)-dependent membrane fusion. J Med Virol. 2021;93:5825\u201332.","journal-title":"J Med Virol"},{"key":"5447_CR64","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41419-020-03252-9","volume":"11","author":"P Wang","year":"2020","unstructured":"Wang P, Luo R, Zhang M, Wang Y, Song T, Tao T, et al. A cross-talk between epithelium and endothelium mediates human alveolar-capillary injury during SARS-CoV-2 infection. Cell Death Dis. 2020;11:1042.","journal-title":"Cell Death Dis"},{"key":"5447_CR65","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3390\/antiox10111677","volume":"10","author":"AM Fratta Pasini","year":"2021","unstructured":"Fratta Pasini AM, Stranieri C, Girelli D, Busti F, Cominacini L. Is ferroptosis a key component of the process leading to multiorgan damage in COVID-19? Antioxidants. 2021;10:1677.","journal-title":"Antioxidants"},{"key":"5447_CR66","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1161\/CIRCRESAHA.121.320518","volume":"130","author":"Y Han","year":"2022","unstructured":"Han Y, Zhu J, Yang L, Nilsson-Payant BE, Hurtado R, Lacko LA, et al. SARS-CoV-2 infection induces ferroptosis of sinoatrial node pacemaker cells. Circulation Res. 2022;130:963\u201377.","journal-title":"Circulation Res"},{"key":"5447_CR67","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2147\/JIR.S353467","volume":"15","author":"R Zhang","year":"2022","unstructured":"Zhang R, Sun C, Chen X, Han Y, Zang W, Jiang C, et al. COVID-19-related brain injury: the potential role of ferroptosis. J Inflamm Res. 2022;15:2181\u201398.","journal-title":"J Inflamm Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05447-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05447-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T11:31:23Z","timestamp":1669548683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-05447-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,26]]},"references-count":67,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["5447"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-05447-8","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,26]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1000"}}